Biogen Inc. (BIIB)

Biogen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,759	2,375	1,050	3,419	2,261	1,331
Short-Term Investments	-	-	-	1,474	1,541	1,279
Cash & Short-Term Investments	2,759	2,375	1,050	4,893	3,803	2,610
Cash Growth	44.52%	126.21%	-78.54%	28.67%	45.68%	-41.69%
Accounts Receivable	1,624	1,405	1,664	1,705	1,549	1,914
Other Receivables	459.8	464	435.9	431.4	412.3	413.5
Total Trade Receivables	2,084	1,869	2,100	2,136	1,962	2,327
Inventory	2,274	2,461	2,527	1,344	1,352	1,069
Other Current Assets	850.6	752.5	1,182	1,418	740.8	881.1
Total Current Assets	7,968	7,457	6,859	9,791	7,857	6,887
Net Property, Plant & Equipment	334.5	356.4	420	403.9	375.4	433.3
Other Intangible Assets	9,468	9,691	8,363	1,850	2,221	3,084
Goodwill	6,493	6,479	6,219	5,749	5,761	5,762
Long-Term Investments	637.7	560.5	745	2,235	2,832	3,671
Other Long-Term Assets	330.9	324.2	928.6	1,226	1,415	1,370
Total Assets	28,330	28,049	26,845	24,554	23,877	24,619
Accounts Payable	408.4	424.2	403.3	491.5	589.2	454.9
Accrued Expenses	2,661	2,808	2,624	2,521	2,535	3,145
Current Portion of Long-Term Debt	-	1,749	150	-	999.1	-
Other Current Liabilities	114.8	548.3	257.4	259.9	174.7	142
Total Current Liabilities	3,184	5,529	3,434	3,273	4,298	3,742
Long-Term Debt	6,284	4,547	6,788	6,281	6,274	7,426
Long-Term Leases	310.9	334.5	400	333	330.4	402
Other Long-Term Liabilities	917.9	922.8	1,423	1,279	2,015	2,362
Total Long-Term Liabilities	7,513	5,805	8,611	7,893	8,619	10,191
Total Liabilities	10,696	11,333	12,045	11,166	12,918	13,933
Preferred Stock	-	-	-	-	-	0.1
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1
Treasury Stock	-2,977	-2,977	-2,977	-2,977	-2,977	-2,977
Additional Paid-in Capital	714	569.4	302.5	73.3	68.2	-
Accumulated Other Comprehensive Income	-238.1	-136.2	-153.7	-164.9	-106.7	-299
Retained Earnings	20,135	19,260	17,628	16,467	13,912	13,976
Total Common Shareholders' Equity	17,634	16,716	14,799	13,398	10,896	10,700
Minority Interest	-	-	-	-9.5	63.5	-14.2
Shareholders' Equity	17,634	16,716	14,799	13,388	10,960	10,686
Total Liabilities & Equity	28,330	28,049	26,845	24,554	23,877	24,619
Total Debt	6,595	6,630	7,338	6,614	7,604	7,828
Net Cash (Debt)	-3,836	-4,255	-6,288	-1,721	-3,801	-5,218
Net Cash Per Share	-26.22	-29.17	-43.19	-11.79	-25.41	-32.35
Book Value	17,634	16,716	14,799	13,398	10,896	10,700
Book Value Per Share	120.55	114.57	101.64	91.77	72.84	66.34
Tangible Book Value	1,673	545.9	217.2	5,799	2,914	1,854
Tangible Book Value Per Share	11.44	3.74	1.49	39.72	19.48	11.49

Updated Jul 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q